During the "Lightning Round" segment of Mad Money Thursday night, one caller asked Jim Cramer about Cardlytics (CDLX) : "This looks like the right price to buy into this one," said Cramer.
More from Investing
Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.
IPOs in recent months have done extremely well -- not so GDRX.
Competition from AMD and ARM CPU developers looks set to take a toll over the next two years. But Intel could be in better shape in 2023 if its new CEO is ready to make some tough choices.
What happened after Citron Research posted a video about GameStop is very troubling.